Folic Acid for Prevention of Contrast Induced Nephropathy
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether periprocedural administration of folic acid
is effective in the prevention of contrast induced nephropathy in patients undergoing
coronary CTA/angiography/angioplasty.